The importance of managing cardiovascular risk in the treatment of hypertension: The role of ACE inhibitors and ARBs
CA Pierson, BJ Epstein, ME Roberts - Journal of the American …, 2008 - journals.lww.com
Disclosure: This work was supported by Boehringer Ingelheim Pharmaceuticals, Inc. Each
participant received an honorarium from Boehringer Ingelheim Pharmaceuticals, Inc. for time …
participant received an honorarium from Boehringer Ingelheim Pharmaceuticals, Inc. for time …
Heart failure in the elderly
T Dieterle, M Pfisterer, H Brunner-La Rocca - Aging Health, 2008 - Taylor & Francis
Heart failure is a progressive and often fatal disorder. The prevalence and incidence of heart
failure increase continuously with advancing age. Heart failure imposes an enormous …
failure increase continuously with advancing age. Heart failure imposes an enormous …
Favorable effects of the optimized drug treatment of heart failure on ventricular arrhythmias
EMG God, MCV Moreira… - Arquivos Brasileiros de …, 2008 - SciELO Brasil
Background: Ventricular arrhythmic events have a strong impact on the mortality of patients
with heart failure. The benefits of the optimized drug treatment of heart failure in reducing …
with heart failure. The benefits of the optimized drug treatment of heart failure in reducing …
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension
SE Kjeldsen, T Hedner, K Narkiewicz, S Oparil - Blood Pressure, 2008 - Taylor & Francis
Fixed dose formulations of rational antihypertensive drug combinations are being used
increasingly early in the management of hypertension (1). Fixed combinations for …
increasingly early in the management of hypertension (1). Fixed combinations for …
[PDF][PDF] Canadian Pharmacists Journal
DA Lamb, DF Blackburn, AM PausJenssen… - researchgate.net
Heart failure is a clinical syndrome associated with poor quality of life, frequent hospital
admissions, and high mortality rates. Since the number of people with heart failure is …
admissions, and high mortality rates. Since the number of people with heart failure is …
[PDF][PDF] L'ACADÉMIE NATIONALE DE MÉDECINE
A à la Rédaction, S du Chaffaut - academie-medecine.fr
Il y a exactement un an, le 18 mai 2015, nous apprenions le décès de Christian NEZELOF
notre Confrère, notre ami. Il avait 93 ans. Il était Chevalier de la Légion d'Honneur. Il avait …
notre Confrère, notre ami. Il avait 93 ans. Il était Chevalier de la Légion d'Honneur. Il avait …
[PDF][PDF] Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
J Pogue, L Dyal, I Copland - Citeseer
Background: In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensinconverting-enzyme (ACE) inhibitors reduce mortality and morbidity from …
failure, angiotensinconverting-enzyme (ACE) inhibitors reduce mortality and morbidity from …
[PDF][PDF] Ghid de practică medicală petru diabet, prediabet şi boli cardiovasculare: sumar executiv
MT Force, L Rydén, ES Co-Preşedinte, M Bartnik… - neurologiepediatrica.ro
Ghidurile şi Consensul Experţilor au ca scop să prezinte managementul şi recomandările
bazate pe toate dovezile asupra unor subiecte anume care să ajute medicii să selecteze …
bazate pe toate dovezile asupra unor subiecte anume care să ajute medicii să selecteze …
[PDF][PDF] Hiperpotasemia grave asociada a tratamiento con espironolactona y candesartán
EM Lima Rodríguez, CR JM - semg.info
El estudio RALES, publicado en 1999, demostró que la espironolactona (dosis media de 26
mg/día) asociada a inhibidores de la enzima conversora de la angiotensina (IECA) y un …
mg/día) asociada a inhibidores de la enzima conversora de la angiotensina (IECA) y un …
[PDF][PDF] OS GRANDES ENSAIOS CLÍNICOS
E relação à função Renal - sociedades.cardiol.br
A maior utilização dos BRÁS é como agentes anti-hipertensivos que, segundo os
“Guidelines”(Joint) americanos, apresentam recomendação de uso em certas situações …
“Guidelines”(Joint) americanos, apresentam recomendação de uso em certas situações …